Age-Related Macular Degeneration Global Market Report 2025

Global Age Related Macular Degeneration Market Report 2024

Age-Related Macular Degeneration Global Market Report 2025 – By Type (Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)), By Drug (Eylea, Lucentis, Avastin, Other Products), By Route Of Administration (Intravenous, Intravitreal), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

Name: Age-Related Macular Degeneration Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Age-Related Macular Degeneration Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Age-Related Macular Degeneration Global Market Report 2025

Proud Members Of

Age-Related Macular Degeneration Market Definition

Age-related macular degeneration (AMD) refers to a progressive eye condition in which the macula, which is located at the center of the retina, deteriorates over time in individuals with AMD, leading to a decline in central vision. It is due to aging. The therapy options for age-related macular degeneration include regular eye exams, lifestyle changes, and particular nutritional supplements.

The main types of age-related macular degeneration are wet age-related macular degeneration (AMD) and dry age-related macular degeneration (AMD). Wet age-related macular degeneration refers to a progressive eye disease in which abnormal blood vessels start growing beneath the macula, which is the central part of the retina responsible for sharp, central vision. It uses various drugs such as eylea, lucentis, vastin, and others. It is applied intravenously and intravitreally, and are distributed through hospital pharmacies, specialty pharmacies, and online pharmacies.

Age-Related Macular Degeneration Market Segmentation

The age-related macular degeneration market covered in this report is segmented –

1) By Type: Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)

2) By Drug: Eylea, Lucentis, Avastin, Other Products

3) By Route Of Administration: Intravenous, Intravitreal

4) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy

Subsegments:

1) By Wet Age-Related Macular Degeneration (AMD): Anti-VEGF Injections, photodynamic therapy, Laser Surgery

2) By Dry Age-Related Macular Degeneration (AMD): Nutritional Supplements, Low Vision Aids, Therapies For Geographic Atrophy

Age-Related Macular Degeneration Market Size and growth rate 2025 to 2029: Graph

Age-Related Macular Degeneration Market Size 2025 And Growth Rate

The age-related macular degeneration market size has grown strongly in recent years. It will grow from$9.96 billion in 2024 to $10.7 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to aging population demographics, changing lifestyles and environmental factors, genetic predisposition, increased awareness and early diagnosis, advancements in diagnostic techniques

Age-Related Macular Degeneration Market Growth Forecast

The age-related macular degeneration market size is expected to see strong growth in the next few years. It will grow to $14.38 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to research in genetics and biomarkers, emerging therapeutic modalities, telemedicine and remote monitoring, patient advocacy and education. Major trends in the forecast period include personalized medicine approaches, innovations in retinal imaging technologies, emergence of sustained drug delivery systems, clinical trials for investigational therapies, collaborations for research and development.

Book your 30 minutes free consultation with our research experts

Age-Related Macular Degeneration Market Driver: The Surging Prevalence Of Age-Related Macular Degeneration Sparks Growth In The AMD Market

Rising age-related macular degeneration (AMD) prevalence is expected to propel the growth of the age-related macular degeneration (AMD) market going forward. Age-related macular degeneration (AMD) is a progressive eye condition affecting the macula, a small part of the retina responsible for central vision. Age-related macular degeneration (AMD) treatments support patients suffering from retinal disorders by minimizing the severity of the disease condition. For instance, in February 2023, according to the reports shared by Optimaxa., a UK-based laser eye treatment specialist, age-related macular degeneration (AMD) affected 196 million individuals globally and is expected to reach 288 million in 2040, accounting for 8.7 percent of the world's population. Therefore, rising age-related macular degeneration (AMD) prevalence is driving the age-related macular degeneration market.

Age-Related Macular Degeneration Market Driver: The Pivotal Role Of A Growing Aging Population In Fueling The Age-Related Macular Degeneration Market

The growing aging population market is expected to propel the growth of the age-related macular degeneration market going forward. The aging population refers to a demographic shift characterized by a higher proportion or an increasing number of individuals in a society who are aged 65 years and older. With a rising number of elderly individuals globally, there is a parallel surge in the prevalence of AMD, a progressive eye condition affecting central vision. For instance, in January 2024, according to the Population Reference Bureau, a US-based Nonprofit organization, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. This age group’s share of the overall population is also projected to rise from 17% to 23% during the same period. Therefore, the growing aging population is driving the growth of the age-related macular degeneration market.

Global Age-Related Macular Degeneration Market Major Players

Major companies operating in the age-related macular degeneration market include F. Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Pfizer Inc., Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Amgen Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., AbbVie Inc., Outlook Therapeutics Inc., Biogen Inc., Samsung Bioepis Co. Ltd., Biocon Ltd., Bio-Thera Biopharmaceutical Co. Ltd., AstraZeneca plc, Acucela Inc., Ophthotech Corporation, Kodiak Sciences Inc., REGENXBIO Inc., Alkahest Inc., Opthea Limited, Apellis Pharmaceuticals Inc., Graybug Vision Inc., IVERIC bio Inc., Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., Tyrogenex Inc., Chengdu Kanghong Pharmaceutical Group Co. Ltd., I-Mab Biopharma Co. Ltd., pSivida Corp., Clearside Biomedical Inc., SciFluor Life Sciences LLC, Lineage Cell Therapeutics Inc.

Global Age-Related Macular Degeneration Market Trend: Innovative Treatments for Age-Related Macular Degeneration: Focus on Bispecific Antibodies

Major companies in the age-related macular degeneration (AMD) market are developing innovative treatments, such as bispecific antibodies, for reduced treatment frequency. A bispecific antibody is an engineered antibody capable of binding to two different antigens simultaneously. For instance, in May 2022, Chugai Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, launched Vabysmo intravitreal injection 120 mg/mL, a bispecific antibody designed for treating eye conditions like age-related macular degeneration (AMD) and diabetic macular edema (DME). This groundbreaking therapy operates by concurrently targeting two essential pathways: angiopoietin-2 (Ang-2), which contributes to abnormal blood vessel growth and inflammation, and Vascular Endothelial Growth Factor-A (VEGF-A), a major factor in the formation of new blood vessels that can lead to vision loss. One of the key benefits of Vabysmo is its extended dosing intervals, enabling treatments to be administered every 16 weeks, which enhances patient convenience and adherence. Its dual-action approach marks significant progress in ophthalmic treatments, effectively addressing the urgent need for reliable therapies in retinal diseases.

Global Age-Related Macular Degeneration Market Trend: Advancements in AMD Therapy: The Role of Fab and MAR Systems

Major companies in the age-related macular degeneration (AMD) market are advancing innovative technologies, such as recombinant antigen-binding fragments. Recombinant antigen-binding fragments (Fab) are engineered proteins derived from antibodies that specifically bind to target antigens, commonly utilized in therapeutic applications to inhibit disease-related pathways. For instance, in December 2023, Enzene Biosciences, an India-based, biotechnology company, launched ranibizumab, a recombinant monoclonal antibody fragment (Fab) specifically engineered to inhibit vascular endothelial growth factor (VEGF), a key protein involved in the development of abnormal blood vessels in conditions such as age-related macular degeneration (AMD) and diabetic macular edema (DME). By obstructing VEGF, ranibizumab effectively decreases the leakage and proliferation of these blood vessels, which helps preserve vision in patients with these retinal disorders. It is delivered through intravitreal injection and has gained widespread acceptance in clinical practice for its efficacy in treating various retinal diseases. The introduction of ranibizumab has greatly enhanced the treatment landscape for patients grappling with these serious conditions.

Age-Related Macular Degeneration Market Merger And Acquisition: Astellas Pharma's Strategic Acquisition Of Iveric Bio Inc. For $5.9 Billion

In May 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, acquired IVERIC Bio Inc., for $5.9 billion. Through this acquisition, Astellas Pharma Inc. aims to expand its presence in the ophthalmology market and accelerate the development of novel treatments in the field of ophthalmology. IVERIC Bio Inc. is a US-based biotech corporation that develops age-related macular degeneration drugs and products for treatment.

Regional Analysis For The Global Age-Related Macular Degeneration Market

North America was the largest region in the global age-related macular degeneration market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the age-related macular degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the age-related macular degeneration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Age-Related Macular Degeneration Market?

The age-related macular degeneration market consists of sales of anti-vascular endothelial growth factor (anti-VEGF) drugs, photodynamic therapy (PDT), low-vision aids, and telescopic lenses. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Age-Related Macular Degeneration Industry?

The age-related macular degeneration market research report is one of a series of new reports from The Business Research Company that provides age-related macular degeneration market statistics, including age-related macular degeneration industry global market size, regional shares, competitors with an age-related macular degeneration market share, detailed age-related macular degeneration market segments, market trends and opportunities, and any further data you may need to thrive in the age-related macular degeneration industry. This age-related macular degeneration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Age-Related Macular Degeneration Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$10.7 billion
Revenue Forecast In 2034	$14.38 billion
Growth Rate	CAGR of 7.7% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD) 2) By Drug: Eylea, Lucentis, Avastin, Other Products 3) By Route Of Administration: Intravenous, Intravitreal 4) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy Subsegments: 1) By Wet Age-Related Macular Degeneration (AMD): Anti-VEGF Injections, Photodynamic Therapy, Laser Surgery 2) By Dry Age-Related Macular Degeneration (AMD): Nutritional Supplements, Low Vision Aids, Therapies For Geographic Atrophy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Pfizer Inc., Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Amgen Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., AbbVie Inc., Outlook Therapeutics Inc., Biogen Inc., Samsung Bioepis Co. Ltd., Biocon Ltd., Bio-Thera Biopharmaceutical Co. Ltd., AstraZeneca plc, Acucela Inc., Ophthotech Corporation, Kodiak Sciences Inc., REGENXBIO Inc., Alkahest Inc., Opthea Limited, Apellis Pharmaceuticals Inc., Graybug Vision Inc., IVERIC bio Inc., Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., Tyrogenex Inc., Chengdu Kanghong Pharmaceutical Group Co. Ltd., I-Mab Biopharma Co. Ltd., pSivida Corp., Clearside Biomedical Inc., SciFluor Life Sciences LLC, Lineage Cell Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Age-Related Macular Degeneration Market Characteristics

3. Age-Related Macular Degeneration Market Trends And Strategies

4. Age-Related Macular Degeneration Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Age-Related Macular Degeneration Growth Analysis And Strategic Analysis Framework

5.1. Global Age-Related Macular Degeneration PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Age-Related Macular Degeneration Market Growth Rate Analysis

5.4. Global Age-Related Macular Degeneration Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Age-Related Macular Degeneration Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Age-Related Macular Degeneration Total Addressable Market (TAM)

6. Age-Related Macular Degeneration Market Segmentation

6.1. Global Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Wet Age-Related Macular Degeneration (AMD)

Dry Age-Related Macular Degeneration (AMD)

6.2. Global Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Eylea

Lucentis

Avastin

Other Products

6.3. Global Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous

Intravitreal

6.4. Global Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Specialty Pharmacy

Online Pharmacy

6.5. Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Wet Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anti-VEGF Injections

Photodynamic Therapy

Laser Surgery

6.6. Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Dry Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nutritional Supplements

Low Vision Aids

Therapies For Geographic Atrophy

7. Age-Related Macular Degeneration Market Regional And Country Analysis

7.1. Global Age-Related Macular Degeneration Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Age-Related Macular Degeneration Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Age-Related Macular Degeneration Market

8.1. Asia-Pacific Age-Related Macular Degeneration Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Age-Related Macular Degeneration Market

9.1. China Age-Related Macular Degeneration Market Overview

9.2. China Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Age-Related Macular Degeneration Market

10.1. India Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Age-Related Macular Degeneration Market

11.1. Japan Age-Related Macular Degeneration Market Overview

11.2. Japan Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Age-Related Macular Degeneration Market

12.1. Australia Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Age-Related Macular Degeneration Market

13.1. Indonesia Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Age-Related Macular Degeneration Market

14.1. South Korea Age-Related Macular Degeneration Market Overview

14.2. South Korea Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Age-Related Macular Degeneration Market

15.1. Western Europe Age-Related Macular Degeneration Market Overview

15.2. Western Europe Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Age-Related Macular Degeneration Market

16.1. UK Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Age-Related Macular Degeneration Market

17.1. Germany Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Age-Related Macular Degeneration Market

18.1. France Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Age-Related Macular Degeneration Market

19.1. Italy Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Age-Related Macular Degeneration Market

20.1. Spain Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Age-Related Macular Degeneration Market

21.1. Eastern Europe Age-Related Macular Degeneration Market Overview

21.2. Eastern Europe Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Age-Related Macular Degeneration Market

22.1. Russia Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Age-Related Macular Degeneration Market

23.1. North America Age-Related Macular Degeneration Market Overview

23.2. North America Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Age-Related Macular Degeneration Market

24.1. USA Age-Related Macular Degeneration Market Overview

24.2. USA Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Age-Related Macular Degeneration Market

25.1. Canada Age-Related Macular Degeneration Market Overview

25.2. Canada Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Age-Related Macular Degeneration Market

26.1. South America Age-Related Macular Degeneration Market Overview

26.2. South America Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Age-Related Macular Degeneration Market

27.1. Brazil Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Age-Related Macular Degeneration Market

28.1. Middle East Age-Related Macular Degeneration Market Overview

28.2. Middle East Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Age-Related Macular Degeneration Market

29.1. Africa Age-Related Macular Degeneration Market Overview

29.2. Africa Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Age-Related Macular Degeneration Market Competitive Landscape And Company Profiles

30.1. Age-Related Macular Degeneration Market Competitive Landscape

30.2. Age-Related Macular Degeneration Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Age-Related Macular Degeneration Market Other Major And Innovative Companies

31.1. Regeneron Pharmaceuticals Inc.

31.2. Amgen Inc.

31.3. Alimera Sciences Inc.

31.4. Alkeus Pharmaceuticals Inc.

31.5. AbbVie Inc.

31.6. Outlook Therapeutics Inc.

31.7. Biogen Inc.

31.8. Samsung Bioepis Co. Ltd.

31.9. Biocon Ltd.

31.10. Bio-Thera Biopharmaceutical Co. Ltd.

31.11. AstraZeneca plc

31.12. Acucela Inc.

31.13. Ophthotech Corporation

31.14. Kodiak Sciences Inc.

31.15. REGENXBIO Inc.

32. Global Age-Related Macular Degeneration Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Age-Related Macular Degeneration Market

34. Recent Developments In The Age-Related Macular Degeneration Market

35. Age-Related Macular Degeneration Market High Potential Countries, Segments and Strategies

35.1 Age-Related Macular Degeneration Market In 2029 - Countries Offering Most New Opportunities

35.2 Age-Related Macular Degeneration Market In 2029 - Segments Offering Most New Opportunities

35.3 Age-Related Macular Degeneration Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Wet Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Dry Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Age-Related Macular Degeneration Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Age-Related Macular Degeneration Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: F. Hoffmann-La Roche Ltd. Financial Performance

Table 78: Novartis AG Financial Performance

Table 79: Bayer AG Financial Performance

Table 80: Pfizer Inc. Financial Performance

Table 81: Bausch Health Companies Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Wet Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Dry Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Age-Related Macular Degeneration Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Age-Related Macular Degeneration Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 78: Novartis AG Financial Performance

Figure 79: Bayer AG Financial Performance

Figure 80: Pfizer Inc. Financial Performance

Figure 81: Bausch Health Companies Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Macular Degeneration Treatment Global Market Report 2025 – By Stage of Disease (Early-Stage AMD, Intermediate AMD, Late-Stage AMD), By End User (Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals), By Route of Administration (Oral, Injectable, Other Route of Administration), By Types (Wet Macular Degeneration, Dry Macular Degeneration) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Dry Eye Medication Global Market Report 2025 – By Type Of Product (Aqueous, Evaporative, Aqueous and Evaporative), By Delivery System (Liquid, Gel, Ointment, Other Delivery System), By Prescription Type (OTC Drugs, Prescription Drugs), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Eyewear Global Market Report 2025 – By Product (Contact Lenses, Spectacles, Sunglasses), By Gender (Men, Women, Unisex), By Distribution Channel (Optical Stores, Independent Brand Showrooms, Online Stores, Retail Stores) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Newborn Eye Imaging Systems Global Market Report 2025 – By Disease Type (Retinopathy Of Prematurity (ROP), Retinal Disease, Strabismus, Refractive Error, Color Blindness, Other Disease Types), By Device Type (Basic Device, Wireless Device ), By End User (Hospitals, Ophthalmology Diagnosis Centers, Ambulatory Surgical Centers, Other End Users ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

HPV Associated Disorders Global Market Report 2025 – By Indication (Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts, Other Indications), By Therapy (Prevention, Treatment), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Post-Traumatic Stress Disorder Therapeutics Global Market Report 2025 – By Drug Class (Antidepressants, Anti-Anxiety, Antihypertensive, Monoamine Oxidase (MAOs), Antipsychotics Or Second Generation Antipsychotics (SGOs), Beta-Blockers, Other Classes), By Age Group (Pediatric, Geriatric, Adult), By End User (Mental Health Center, Hospitals, Outpatient Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Generic Musculoskeletal Disorders Drugs Global Market Report 2025 – By Treatment Type (Medication, Therapy, Surgery, Other Treatment Types), By Disorder Type (Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types), By Route of Administration (Oral, Parenteral, Other Routes), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Bleeding Disorders Treatment Global Market Report 2025 – By Treatment (Desmopressin (DDAVP), Hormone Replacement Therapy, Contraceptives, Anti-Fibrinolytic or Clot-Stabilizing Drugs, Fibrin Sealants, Drugs Applied To Cuts, Pipeline Analysis), By Disease Type (Hemophilia A, Hemophilia B, Von willebrand disease, Liver disease, Other Disease Types), By End User (Hospitals, Clinics, Specialty Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Age-Related Macular Degeneration market?

How will the Age-Related Macular Degeneration market drivers and restraints affect the market dynamics? What forces will shape the Age-Related Macular Degeneration industry going forward?

The Age-Related Macular Degeneration market major growth driver - The Surging Prevalence Of Age-Related Macular Degeneration Sparks Growth In The AMD Market. For further insights on the Age-Related Macular Degeneration market, request a sample here

What is the forecast market size or the forecast market value of the Age-Related Macular Degeneration market?

The Age-Related Macular Degeneration market size has grown strongly in recent years. The age-related macular degeneration market size has grown strongly in recent years. It will grow from$9.96 billion in 2024 to $10.7 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to aging population demographics, changing lifestyles and environmental factors, genetic predisposition, increased awareness and early diagnosis, advancements in diagnostic techniques The age-related macular degeneration market size is expected to see strong growth in the next few years. It will grow to $14.38 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to research in genetics and biomarkers, emerging therapeutic modalities, telemedicine and remote monitoring, patient advocacy and education. Major trends in the forecast period include personalized medicine approaches, innovations in retinal imaging technologies, emergence of sustained drug delivery systems, clinical trials for investigational therapies, collaborations for research and development. For further insights on the Age-Related Macular Degeneration market, request a sample here

How is the Age-Related Macular Degeneration market segmented?

The age-related macular degeneration market covered in this report is segmented –
1) By Type: Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)
2) By Drug: Eylea, Lucentis, Avastin, Other Products
3) By Route Of Administration: Intravenous, Intravitreal
4) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy Subsegments:
1) By Wet Age-Related Macular Degeneration (AMD): Anti-VEGF Injections, Photodynamic Therapy, Laser Surgery
2) By Dry Age-Related Macular Degeneration (AMD): Nutritional Supplements, Low Vision Aids, Therapies For Geographic Atrophy For further insights on the Age-Related Macular Degeneration market, request a sample here

Which region has the largest share of the Age-Related Macular Degeneration market? What are the other regions covered in the report?

North America was the largest region in the global age-related macular degeneration market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the age-related macular degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Age-Related Macular Degeneration market, request a sample here.

Who are the major players in the Age-Related Macular Degeneration market?

What are the key trends in the Age-Related Macular Degeneration market?

Major trends in the Age-Related Macular Degeneration market include Innovative Treatments for Age-Related Macular Degeneration: Focus on Bispecific Antibodies. For further insights on the Age-Related Macular Degeneration market, request a sample here.

What are the major opportunities in the Age-Related Macular Degeneration market? What are the strategies for the Age-Related Macular Degeneration market?

For detailed insights on the major opportunities and strategies in the Age-Related Macular Degeneration market, request a sample here.

How does the Age-Related Macular Degeneration market relate to the overall economy and other similar markets?

For detailed insights on Age-Related Macular Degeneration's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Age-Related Macular Degeneration industry?

For detailed insights on the mergers and acquisitions in the Age-Related Macular Degeneration industry, request a sample here.

What are the key dynamics influencing the Age-Related Macular Degeneration market growth? SWOT analysis of the Age-Related Macular Degeneration market.

For detailed insights on the key dynamics influencing the Age-Related Macular Degeneration market growth and SWOT analysis of the Age-Related Macular Degeneration industry, request a sample here.